episode-header-image

Jun 2025

27m 31s

mRNA and the Future of Personalized Medi...

Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy

About this episode

Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.

Mentioned

Sandra Barbosu, “Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry,” (ITIF, November 2024)
Richard Fleischer, dir. Fantastic Voyage, (20th Century-Fox, 1966).

Related

Stephen Ezell and Meghan Ostertag, “The Bayh-Dole Act’s Role in Stimulating University-Led Regional Economic Growth,” (ITIF, June 2025)

Up next

The Case for Smarter AI Regulation, With Matt Perault

Regulating how AI is used—not how it's built—is the only way to protect innovation and give small startups a fair shot. Rob and Jackie sit down with Matt Perault, Head of Artificial Intelligence Policy at Andreessen Horowitz, to discuss the significant burden regulatory framework ... Show More

Decoding the Techno-Economic Power Struggle, With Alex Capri

There is a clear linkage between technology and national security, economic strength and social stability. Rob and Jackie sit down with Alex Capri, author of Techno-Nationalism: How It's Reshaping Trade, Geopolitics and Society to discuss how nations leverage technological i ... Show More

New Podcast: The Trade War With Stan McCoy

In the inaugural episode of the Information Technology and Innovation Foundation's Trade War Podcast, host Stan McCoy discusses recent developments and challenges in global trade policy with Ambassador Susan C. Schwab and Rob Atkinson. The conversation covers the latest U.S. ... Show More

Recommended Episodes

101: Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen

The late Steve Jobs of Apple said “I think the biggest innovation of the 21st century will be at the intersection of biology and technology, a new era is beginning”. If you want see how biotech can change the world of health, whilst potentially being capable of creating extraordi ... Show More

Biotech Special: a16z and the Biotech Revolution with Vijay Pande

There is a revolution unfolding in biotech. The confluence of new biological methods like CRISPR, virtually unlimited computational capacity, and machine learning has fundamentally transformed our ability to engineer biology for wide-ranging applications. Andreessen Horowitz, or ... Show More

A look at the technology trends that matter most

Innovation and interest in the tech sector remain strong, despite market challenges and dips in investment. On this episode of The McKinsey Podcast, McKinsey technology experts Lareina Yee and Roger Roberts share findings from the McKinsey Technology Trends Outlook 2024 report. T ... Show More

Using AI to Be a More Effective Leader | Innovative Leadership Institute's Maureen Metcalf | Artificial Intelligence Podcast

In this episode of the AI For All Podcast, Maureen Metcalf, CEO and Founder of the Innovative Leadership Institute, joins Ryan Chacon and Neil Sahota to discuss how business leaders can guide their organizations through the age of AI. The conversation covers the complexities of d ... Show More

Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ... Show More

R&D Renaissance with Kumar Garg

To discuss America’s comparative advantages in national competition and the structural forces that drive (and limit) innovation, ChinaTalk interviewed Kumar Garg. Formerly an Obama official in the Office of Science and Technology Policy, Kumar spent several years at Schmidt Futur ... Show More

AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals

Today’s guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI is i ... Show More

Elevating Computer Vision and Female Voices with Alex Levinson and Sheila Beladinejad

In this episode of the DSS Podcast, Anna Anisin introduces two powerhouse guests in the realms of AI and robotics. First, Anna welcomes Alex, Principal Algorithms/AI Engineer at Elbit Systems of America, based in Miami. Alex shares her journey into the field of AI, particularly c ... Show More

Bringing Trust and Guardrails into Developing Enterprise AI Systems - with Steve Jones of Capgemini

Today’s guest is Steve Jones, Executive Vice President of Data Driven Business & GenAI at Capgemini. Together with Emerj Senior Editor Matthew DeMello, Steve joins us on today’s program to examine the evolving landscape of AI development and the critical need for trust and ethica ... Show More

Conference Catch-Up: BIO-Europe 2024

Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI. At BIO-Europe, Norstella's subject matter experts explored key trends shaping the industry, from market access strategies to sustaining growth through partnerships. I ... Show More

Listen to millions of songs and podcasts on Anghami